6-K
File 001-15170
FDA TO REVIEW GONORRHEA INDICATION FOR GEPOTIDACIN
- Filing date
- 11 Aug 2025
- Reporting date
- 11 Aug 2025
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
GSK plc reports
- Company location
- London
GSK plc has filed 6,846 SEC EDGAR filings since 12 Jan 2001
SEC filing history
Showing 376-400 of 1,000 matching filings.
Per page
25
Current page
16
6-K
File 001-15170
TRANSACTION IN OWN SHARES
- Filing date
- 11 Aug 2025
- Reporting date
- 11 Aug 2025
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
CUREVAC/BIONTECH MRNA PATENT LITIGATION SETTLEMENT
- Filing date
- 08 Aug 2025
- Reporting date
- 08 Aug 2025
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
TRANSACTION IN OWN SHARES
- Filing date
- 08 Aug 2025
- Reporting date
- 08 Aug 2025
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
TRANSACTION IN OWN SHARES
- Filing date
- 07 Aug 2025
- Reporting date
- 07 Aug 2025
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
TRANSACTION IN OWN SHARES
- Filing date
- 06 Aug 2025
- Reporting date
- 06 Aug 2025
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
TRANSACTION IN OWN SHARES
- Filing date
- 05 Aug 2025
- Reporting date
- 05 Aug 2025
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
TRANSACTION IN OWN SHARES
- Filing date
- 04 Aug 2025
- Reporting date
- 04 Aug 2025
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
TOTAL VOTING RIGHTS
- Filing date
- 01 Aug 2025
- Reporting date
- 01 Aug 2025
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
TRANSACTION IN OWN SHARES
- Filing date
- 01 Aug 2025
- Reporting date
- 01 Aug 2025
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
TRANSACTION IN OWN SHARES
- Filing date
- 31 Jul 2025
- Reporting date
- 31 Jul 2025
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
2ND QUARTER RESULTS
- Filing date
- 30 Jul 2025
- Reporting date
- 30 Jul 2025
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
TRANSACTION IN OWN SHARES
- Filing date
- 30 Jul 2025
- Reporting date
- 30 Jul 2025
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
TRANSACTION IN OWN SHARES
- Filing date
- 29 Jul 2025
- Reporting date
- 29 Jul 2025
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
GSK ENTERS HENGRUI PHARMA COLLABORATION AGREEMENTS
- Filing date
- 28 Jul 2025
- Reporting date
- 28 Jul 2025
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
PRIMARY DOCUMENT
- Filing date
- 28 Jul 2025
- Reporting date
- 28 Jul 2025
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
TRANSACTION IN OWN SHARES
- Filing date
- 25 Jul 2025
- Reporting date
- 25 Jul 2025
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
BLENREP APPROVED IN THE EU FOR MULTIPLE MYELOMA
- Filing date
- 24 Jul 2025
- Reporting date
- 24 Jul 2025
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
TRANSACTION IN OWN SHARES
- Filing date
- 24 Jul 2025
- Reporting date
- 24 Jul 2025
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
US FDA REVIEW EXTENDED FOR BLENREP
- Filing date
- 23 Jul 2025
- Reporting date
- 23 Jul 2025
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
TRANSACTION IN OWN SHARES
- Filing date
- 23 Jul 2025
- Reporting date
- 23 Jul 2025
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
TRANSACTION IN OWN SHARES
- Filing date
- 22 Jul 2025
- Reporting date
- 22 Jul 2025
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
TRANSACTION IN OWN SHARES
- Filing date
- 21 Jul 2025
- Reporting date
- 21 Jul 2025
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 18 Jul 2025
- Reporting date
- 18 Jul 2025
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
BLENREP US ODAC OUTCOME
- Filing date
- 18 Jul 2025
- Reporting date
- 18 Jul 2025
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing